Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Roberto Faggiuolo"'
1
Safety and Activity of Docetaxel and Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer
Autor: Attilio Salomone, Massimo Aglietta, Gabriella Choa, Antonio Capaldi, Michela Donadio, Elisa Sperti, Monica Minischetti, Oscar Alabiso, Roberto Faggiuolo, Filippo Montemurro, Guido Vietti-Ramus
Publikováno v: American Journal of Clinical Oncology. 26:95-97
We conducted a pilot phase II trial of trastuzumab administered concurrently with docetaxel in women with HER2-overexpressing advanced breast cancer. Twenty-five women with HER2-positive (3+ by immunohistochemistry = 16, 2+ = 9) metastatic breast can
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8314d2d67de6fd7d06c057f7f1f8fe93
https://doi.org/10.1097/01.coc.0000017087.19671.05
Zobrazit plný text záznamu
3
Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis
Autor: Roberto Vormola, Massimo Aglietta, Roberto Faggiuolo, Cinzia Ortega, Daniela Nanni, Marco Ottavio Gilardino, Filippo Montemurro, Franco Goia
Osteonecrosis of the jaw (ONJ) has recently been reported as a potentially serious complication of prolonged treatment with intravenous bisphosphonates. We studied its frequency in prostate cancer patients receiving intravenous zoledronate. The medic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39ea322e43315acf36867b99e560c50
http://hdl.handle.net/2318/21937
Zobrazit plný text záznamu
6
Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer
Autor: Elisa Sperti, A. Magnino, P. Massucco, Roberto Faggiuolo, L. Capussotti, Massimo Aglietta, D. Regge, Pietro Gabriele, Marco Gatti
Objectives: Primary chemoradiotherapy for locally advanced pancreatic cancer (LAPC) may improve local control, curative resection rate and long-term survival. We performed a phase II study to evaluate toxicity and activity of primary radiation therap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9bd764265a0b5424255e9efbb2336e
http://hdl.handle.net/2318/30634
Zobrazit plný text záznamu
7
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer
Autor: Massimo Aglietta, Oscar Alabiso, Roberto Faggiuolo, Gabriella Choa, Michela Donadio, Antonio Durando, Antonio Capaldi, Guido Vietti-Ramus, Filippo Montemurro, Monica Minischetti
Publikováno v: Oncology. 66(1)
Background: To test safety and activity of 3-weekly doses of docetaxel and a weekly dose of trastuzumab in women with HER2-overexpressing advanced breast cancer. Patients and Methods: Forty-two women, median age 53 years (range 36–73 years), with H
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5372de4161a3242486d4ac869bcb7cd
https://pubmed.ncbi.nlm.nih.gov/15031597
Zobrazit plný text záznamu
8
Phase II trial of induction GEMOX followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer
Autor: Roberto Faggiuolo, Pietro Gabriele, Massimo Aglietta, P. Massucco, Francesco Leone, Elisa Sperti, A. Magnino, Lorenzo Capussotti, Sandra Aliberti, Marco Gatti
Publikováno v: Journal of Clinical Oncology. 24:14019-14019
14019 Background: Combined chemo-radiation therapy may render curative resection feasible in pancreatic cancer deemed unresectable for vascular invasion. We previously demonstrated that primary radiotherapy with concurrent gemcitabine is feasible and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7b540af3b7c400a92f77f158799b5ca1
https://doi.org/10.1200/jco.2006.24.18_suppl.14019
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje